Clinical Trial of EPASS With Hot AXIOS System
About the study
A prospective, multi-center, single-arm study for unresectable malignant gastric outlet obstruction with EUS-guided double-balloon-occluded gastrojejunostomy bypass (EPASS)
Who can take part
You may be eligible to participate in the study if you meet the following criteria:
INCLUSION CRITERIA
Inclusion Criteria:
- Unresectable malignant duodenal obstruction confirmed by biopsy
- Eligible for endoscopic intervention
- GOOSS score of 0 or 1
- 18 years of age or older
- Willing and able to comply with the study procedures or legally authorized representative (LAR) must provide written informed consent form (ICF) to participate in the study
EXCLUSION CRITERIA
Exclusion Criteria:
- GOO symptoms are not expected to improve after the index procedure
- Life expectancy is about 3 months or less, which is not assumed applicable for surgical GJ
- Prior metallic stent placement for GOO
- Contraindicated to surgery and general anesthesia
- Neoplasm invading the target site of puncture in gastric and/or jejunum
- Abnormal coagulation INR > 1.5 and not correctable (per the discretion of the physician) or who require continuous complete anticoagulation
- Bleeding diathesis
- Altered anatomy of the upper gastrointestinal tract due to surgery of esophagus, stomach and duodenum that might preclude endoscopic drainage
- Presence of ileus caused by peritoneal carcinomatosis, or expected to present within 30 days post procedure
- Intervening gastric varices or vessels at the target site of stent insertion
- Ascites that may interfere the safety of the index procedure
- Biliary tract obstruction requiring treatment at the same day of the index procedure
- Allergic to any of the device materials
- Contraindications to use of electrosurgical devices
- Pregnancy, breastfeeding or intending to become pregnant during the study period
- Subject is currently participating, or plans to participate in, another investigational trial that may confound the results of this trial (unless written approval is received from the study sponsor)
- Vulnerable subject
- Subject has other reason not to be eligible for this study per investigators' discretion
- Guidewire doesn't cross the area of GOO
- EP-DB doesn't advance to the target site in jejunum
- The distance between the gastric wall and jejunal wall when visualized on ultrasound after saline is introduced into the space between the two inflated balloons of EP-DB is deemed about 2 cm or more
Study Locations
Enter your ZIP code/Postal code/PIN code to locate study sites near you:
How to Apply
Contact the study center to learn if this study is a good match for you.
Study’s details
Contition
Gastric Outlet Obstruction
Age (in years)
18+
Phase
Not Applicable
Participants needed
51
Est. Completion Date
Oct 31, 2024
Treatment type
Interventional
Sponsor
Boston Scientific Corporation
ClinicalTrials.gov identifier
NCT05644951
Study number
E7127
Understanding Clinical Trials
Get answers to your questions about clinical trials.What is a clinical research?What does taking part in clinical trials involve?What should I ask the trial doctor?